Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ulrike Donat"'
Autor:
Ulrike Donat, Juliane Rother, Simon Schäfer, Michael Hess, Barbara Härtl, Christina Kober, Johanna Langbein-Laugwitz, Jochen Stritzker, Nanhai G Chen, Richard J Aguilar, Stephanie Weibel, Aladar A Szalay
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98533 (2014)
More than 90% of cancer mortalities are due to cancer that has metastasized. Therefore, it is crucial to intensify research on metastasis formation and therapy. Here, we describe for the first time the metastasizing ability of the human cervical canc
Externí odkaz:
https://doaj.org/article/11c1d7b2727c44d8b1412e60705b06e3
Autor:
Ivaylo Gentschev, Marion Adelfinger, Rafael Josupeit, Stephan Rudolph, Klaas Ehrig, Ulrike Donat, Stephanie Weibel, Nanhai G Chen, Yong A Yu, Qian Zhang, Martin Heisig, Douglas Thamm, Jochen Stritzker, Amy Macneill, Aladar A Szalay
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37239 (2012)
Virotherapy using oncolytic vaccinia virus (VACV) strains is one promising new strategy for canine cancer therapy. In this study we describe the establishment of an in vivo model of canine soft tissue sarcoma (CSTS) using the new isolated cell line S
Externí odkaz:
https://doaj.org/article/0c84a46c4d39427380140cf74e5ba7bb
Autor:
Sandeep S Patil, Ivaylo Gentschev, Marion Adelfinger, Ulrike Donat, Michael Hess, Stephanie Weibel, Ingo Nolte, Alexa Frentzen, Aladar A Szalay
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47472 (2012)
Virotherapy using oncolytic vaccinia virus (VACV) strains is one promising new strategy for cancer therapy. We have previously reported that oncolytic vaccinia virus strains expressing an anti-VEGF (Vascular Endothelial Growth Factor) single-chain an
Externí odkaz:
https://doaj.org/article/6c87bf39880f4e64b392fa7fd68a30ea
Autor:
Ulrike Donat, Stephanie Weibel, Michael Hess, Jochen Stritzker, Barbara Härtl, Julia B Sturm, Nanhai G Chen, Ivaylo Gentschev, Aladar A Szalay
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45942 (2012)
Recently, we showed that the oncolytic vaccinia virus GLV-1h68 has a significant therapeutic potential in treating lymph node metastases of human PC-3 prostate carcinoma in tumor xenografts. In this study, underlying mechanisms of the virus-mediated
Externí odkaz:
https://doaj.org/article/cc2fbe6665ea4955ba71fd96b0b40991
Autor:
Dominik Richter, Ulrike Donat, Michaela van Ooschot, Ina Israel, Jochen Stritzker, Andreas K. Buck, Samuel Samnick
Publikováno v:
Current Cancer Drug Targets. 14:371-379
The α v β 3 integrin is highly expressed in prostate cancer (PCa), in which it is a key player in tumour invasion, angiogenesis and metastasis formation. Therefore, α v β 3 integrin is considered a very promising target for molecular imaging of P
Autor:
Carolin Seubert, Ivaylo Gentschev, Lutz F. Prof. Dr. Dr. H.C. Tietze, Ulrike Donat, Birgit Krewer, Michael Hess, Aladar A. Szalay, Nanhai G. Chen, J M von Hof, Julia B. Sturm, Jochen Stritzker
Publikováno v:
Cancer Gene Therapy
Breast cancer is the most common cause of cancer-related death worldwide, thus remaining a crucial health problem among women despite advances in conventional therapy. Therefore, new alternative strategies are needed for effective diagnosis and treat
Autor:
Jochen Stritzker, Stephanie Weibel, Ivaylo Gentschev, Yong A. Yu, Ulrike Donat, Aladar A. Szalay, Elisabeth Hofmann, Nanhai G. Chen, Martin Heisig, Marion Adelfinger, Viktoria Raab
Publikováno v:
Journal of Biomedicine and Biotechnology
Journal of Biomedicine and Biotechnology, Vol 2010 (2010)
Journal of Biomedicine and Biotechnology, Vol 2010 (2010)
Virotherapy using oncolytic vaccinia virus strains is one of the most promising new strategies for cancer therapy. In the current study, we analyzed the therapeutic efficacy of the oncolytic vaccinia virus GLV-1h68 against two human prostate cancer c
Autor:
Aladar A. Szalay, Nanhai G. Chen, Mehmet O. Kilinc, Lisa Buckel, Klaas Ehrig, Jochen Stritzker, Ulrike Donat
Publikováno v:
Journal of Human Virology & Retrovirology. 2
Colorectal cancer (CRC) detected at an early stage has a good prognosis, however, recurrence of the disease is prevalent and late stage CRC (stage IIIC and IV) has observed 5-year survival rates of 28% and 6%, respectively. Oncolytic virotherapy has
Autor:
Stephanie Weibel, Jochen Stritzker, Johanna Langbein-Laugwitz, Christina Kober, Richard J. Aguilar, Juliane Rother, Ulrike Donat, Michael Hess, Aladar A. Szalay, Nanhai G. Chen, Barbara Härtl, Simon Schäfer
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98533 (2014)
PLoS ONE
PLoS ONE
More than 90% of cancer mortalities are due to cancer that has metastasized. Therefore, it is crucial to intensify research on metastasis formation and therapy. Here, we describe for the first time the metastasizing ability of the human cervical canc
Autor:
Ulrike Donat
Publikováno v:
Kritische Justiz. 31:393-399